<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Nonaneurysmal subarachnoid hemorrhage</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Nonaneurysmal subarachnoid hemorrhage</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Nonaneurysmal subarachnoid hemorrhage</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Farhan Siddiq, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">José Biller, MD, FACP, FAAN, FAHA</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alejandro A Rabinstein, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard P Goddeau, Jr, DO, FAHA</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 13, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Subarachnoid hemorrhage (SAH) refers to intracranial bleeding within the subarachnoid space, which lies between the arachnoid and pia mater overlying the brain. Most cases of spontaneous (nontraumatic) SAH are caused by rupture of an intracranial aneurysm. However, approximately 20 percent of SAH cases are not due to a ruptured intracranial aneurysm. The potential causes of nonaneurysmal SAH (NASAH) are diverse; in some cases, the source of bleeding is not identified.</p><p>This topic will review the etiologies, diagnostic evaluation, and management of NASAH. Aneurysmal SAH is discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/90075.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Epidemiology, risk factors, and pathogenesis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1130.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Clinical manifestations and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1127.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Treatment and prognosis"</a>.)</p><p></p><p>Traumatic SAH and other forms of traumatic brain injury are presented separately. (See  <a class="medical medical_review" href="/d/html/4826.html" rel="external">"Management of acute moderate and severe traumatic brain injury"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">ETIOLOGIES</span></p><p class="headingAnchor" id="H3"><span class="h2">Perimesencephalic nonaneurysmal subarachnoid hemorrhage</span><span class="headingEndMark"> — </span>Perimesencephalic NASAH is a subtype of NASAH identified by a specific pattern of localized blood on computed tomography (CT) of the head and generally characterized by a benign course that distinguishes these patients not only from aneurysmal SAH, but also from other patients with NASAH [<a href="#rid1">1-4</a>].</p><p>The head CT findings that define perimesencephalic NASAH include blood isolated to the perimesencephalic cisterns anterior to the brainstem; there may be extension into the ambient cisterns or basal parts of the Sylvian fissures but not into the lateral Sylvian fissure, anterior interhemispheric fissure, or lateral ventricles  (<a class="graphic graphic_diagnosticimage graphicRef76973" href="/d/graphic/76973.html" rel="external">image 1</a> and <a class="graphic graphic_diagnosticimage graphicRef121315" href="/d/graphic/121315.html" rel="external">image 2</a>) [<a href="#rid4">4,5</a>].</p><p>Perimesencephalic NASAH may be caused by spontaneous rupture of a small perforating artery or vein at the surface of the brainstem. However, in most cases, diagnostic testing is unable to definitively identify the cause of bleeding in perimesencephalic NASAH. In some case series, perimesencephalic NASAH accounts for up to two-thirds of patients with NASAH [<a href="#rid5">5</a>].</p><p>Perimesencephalic NASAH is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/1114.html" rel="external">"Perimesencephalic nonaneurysmal subarachnoid hemorrhage"</a>.)</p><p class="headingAnchor" id="H5"><span class="h2">Vascular malformations</span><span class="headingEndMark"> — </span>Approximately 10 percent of SAH are caused by vascular malformations [<a href="#rid6">6,7</a>]. Vascular malformations of the brain include arteriovenous malformations, dural arteriovenous fistulas, cavernous malformations, developmental venous anomalies, and capillary telangiectasias.</p><p>Intracerebral hemorrhage is the most common hemorrhagic presentation, but vascular malformations near the surface of the brain may present with bleeding primarily or exclusively in the subarachnoid space [<a href="#rid6">6,8-11</a>]. Vascular malformations of the brain that most frequently present with SAH are arteriovenous malformations and dural arteriovenous fistulas. Dural arteriovenous fistulas with cortical venous drainage are associated with high risk for early rebleeding [<a href="#rid10">10,12</a>].</p><p>Most vascular malformations can be visualized on cerebral angiography [<a href="#rid9">9,13,14</a>]. Angiographically occult vascular malformations such as some cavernous malformations, developmental venous anomalies, and capillary telangiectasias are visualized on magnetic resonance imaging (MRI) but are less likely to be a source of intracranial bleeding, including SAH.</p><p>Vascular malformations of the brain are discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/1087.html" rel="external">"Brain arteriovenous malformations"</a> and  <a class="medical medical_review" href="/d/html/1129.html" rel="external">"Vascular malformations of the central nervous system"</a>.)</p><p class="headingAnchor" id="H8"><span class="h2">Intracranial arterial dissection</span><span class="headingEndMark"> — </span>Dissection of an intracranial artery can produce SAH. Intracranial dissection is usually initiated by a tear in the media, producing an intramural hemorrhage [<a href="#rid15">15</a>]. When the tear extends through (or is initiated in) the intima, a false lumen forms and can lead to narrowing of the (true) lumen with subsequent thrombus formation and thromboembolic ischemic stroke. However, if the dissection tears through the adventitia, SAH may occur. SAH is more common with dissections in the vertebrobasilar circulation than the intracranial carotid circulations. If intracranial dissection causes SAH, bleeding is massive and often devastating [<a href="#rid16">16-18</a>].</p><p>Many intracranial dissections are believed to occur in the setting of sudden or unusual stretching of arteries, but such a clinical history is often lacking. While connective tissue diseases such as Ehlers-Danlos syndrome type IV and fibromuscular dysplasia are associated with intracranial arterial dissection, most patients with dissection do not have these conditions. Other risk factors for intracranial dissection include migraine and hypertension.</p><p>Most cases of intracranial arterial dissection in the setting of SAH are diagnosed by conventional cerebral angiography [<a href="#rid1">1,15,17</a>]. Brain MRI with T1-weighted fat saturation sequences may identify acute intramural hemorrhage as a crescent-shaped hyperdensity adjacent to the arterial lumen on cross-sectional images [<a href="#rid15">15</a>]. The clinical features and diagnosis of intracranial arterial dissections are discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/14082.html" rel="external">"Cerebral and cervical artery dissection: Clinical features and diagnosis"</a>.)</p><p>Intracranial dissections are typically treated surgically or with endovascular interventions due to the high risk of morbidity with rebleeding, but natural history data are limited. (See  <a class="medical medical_review" href="/d/html/16649.html" rel="external">"Cerebral and cervical artery dissection: Treatment and prognosis", section on 'Subarachnoid hemorrhage due to intracranial dissection'</a>.)</p><p class="headingAnchor" id="H2935695687"><span class="h2">Reversible cerebral vasoconstriction syndrome</span><span class="headingEndMark"> — </span>Reversible cerebral vasoconstriction syndrome (RCVS) is a condition characterized by multifocal narrowing of the cerebral arteries and a clinical presentation that typically features recurrent thunderclap headaches with or without neurologic deficits. Patients with severe vasospasm may present with ischemic stroke, cerebral edema, and hemorrhagic complications, including SAH, often within the hemispheric convexities. In case series, convexity SAH was present in 33 percent of patients with RCVS [<a href="#rid19">19</a>]. RCVS is thought to involve vasospasm that may be triggered by vasoactive and other medications, medical conditions, or environmental stimuli, but an associated trigger is frequently not identified.</p><p>The presence of recurrent thunderclap headaches is a clinical clue used to distinguish RCVS from aneurysmal SAH. Vascular imaging frequently shows widespread, multifocal narrowing of the cerebral arteries. Cerebral angiography is warranted for patients with atypical symptoms such as those presenting with a single instance of a thunderclap headache or those with SAH at the basal cisterns or Sylvian or interhemispheric fissures. Brain imaging in RCVS may show focal SAH typically within the convexities of one or both cerebral hemispheres. Ischemic lesions may be found at border-zone regions of adjacent vascular territories.</p><p>The management of RCVS is typically supportive, although calcium channel blockers and <a class="drug drug_general" data-topicid="9585" href="/d/drug information/9585.html" rel="external">magnesium sulfate</a> have been used for vasospasm and headaches. Vasoconstriction typically resolves within several weeks. RCVS is discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/14075.html" rel="external">"Reversible cerebral vasoconstriction syndrome"</a>.)</p><p class="headingAnchor" id="H3223774910"><span class="h2">Cerebral venous thrombosis</span><span class="headingEndMark"> — </span>Cerebral venous thrombosis (CVT) causes increased venous pressure that can lead to the development of cerebral edema, venous infarction, and/or hemorrhage. CVT can also present with SAH as its primary manifestation [<a href="#rid6">6,20-24</a>]. The clinical presentation of CVT commonly includes headache with or without focal neurologic symptoms. Onset is typically less abrupt than with aneurysmal rupture and bleeding on neuroimaging is frequently localized and superficial rather than at the basal cisterns.</p><p>CVT may be visualized on noninvasive vascular studies such as a CT or magnetic resonance (MR) venogram or on the venous phase of digital subtraction angiography (DSA) and/or on brain MRI. Management typically includes anticoagulation, even for most patients with hemorrhagic presentations.</p><p>CVT is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/1103.html" rel="external">"Cerebral venous thrombosis: Etiology, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/1109.html" rel="external">"Cerebral venous thrombosis: Treatment and prognosis"</a>.)</p><p class="headingAnchor" id="H1774051732"><span class="h2">Cerebral amyloid angiopathy</span><span class="headingEndMark"> — </span>Cerebral amyloid angiopathy (CAA) most commonly presents with lobar intracerebral brain hemorrhage (ICH), but isolated convexity SAH may also occur. Subarachnoid bleeding may be focal, often restricted to a single sulcus. Associated imaging findings include chronic cortical microbleeds, superficial siderosis, and bilateral subcortical white matter hyperintensities [<a href="#rid25">25-28</a>]. Clinical symptoms vary by location and extent of acute bleeding. Some patients with convexity SAH may present with transient focal neurologic episodes.</p><p>CAA is typically diagnosed by characteristic findings on brain MRI that includes T2*-susceptibility-weighted or gradient-echo sequences. Pathologic confirmation is generally reserved for patients with atypical features.</p><p>The clinical presentation, diagnostic findings, and management of CAA are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/1128.html" rel="external">"Cerebral amyloid angiopathy"</a>.)</p><p class="headingAnchor" id="H1994825399"><span class="h2">Traumatic SAH</span><span class="headingEndMark"> — </span>Trauma is a common cause of intracranial bleeding, including SAH, but is usually identified by the clinical setting. However, the appropriate clinical history may be unavailable for patients who present with confusion or stupor or baseline cognitive impairment, or in the setting of minor trauma not reported or recalled by the patient. In these settings, radiologic clues of a traumatic origin include localized bleeding in superficial sulci, adjacent skull fracture, cerebral contusion, as well as external evidence of traumatic injury [<a href="#rid8">8,29</a>]. Awake patients and any witnesses should be questioned about possible trauma as the cause to SAH. For patients with moderate to severe traumatic brain injury, brain MRI may also show other features typically associated with additional forms of brain injury (eg, intracerebral hemorrhage, diffuse axonal injury)  (<a class="graphic graphic_diagnosticimage graphicRef121315" href="/d/graphic/121315.html" rel="external">image 2</a>). (See  <a class="medical medical_review" href="/d/html/4828.html" rel="external">"Acute mild traumatic brain injury (concussion) in adults"</a> and  <a class="medical medical_review" href="/d/html/4826.html" rel="external">"Management of acute moderate and severe traumatic brain injury"</a>.)</p><p>While trauma can be the cause of SAH, SAH may also lead to trauma (eg, fall). Diagnostic evaluation including cerebral DSA may be indicated for some patients with trauma and SAH when history or imaging pattern of SAH suggests that a ruptured intracranial aneurysm or other etiology may have caused the SAH. (See <a class="local">'Diagnostic evaluation'</a> below.)</p><p class="headingAnchor" id="H3764162894"><span class="h2">Spinal lesions</span><span class="headingEndMark"> — </span>Up to 10 percent of patients with spinal vascular malformations present with SAH [<a href="#rid8">8,30,31</a>]. Dural arteriovenous fistulas are the most common type of spinal vascular malformation [<a href="#rid32">32</a>]. Those that cause SAH are usually, but not always, located in the cervical cord or craniocervical junction [<a href="#rid33">33</a>]. Prominent back or neck pain or myelopathic signs at presentation can indicate this source, but these are often absent and the clinical appearance can mimic that of intracranial aneurysm rupture [<a href="#rid33">33-36</a>]. (See  <a class="medical medical_review" href="/d/html/5093.html" rel="external">"Disorders affecting the spinal cord", section on 'Vascular malformations'</a>.)</p><p>Ruptured spinal aneurysms are a rare source of bleeding in patients with SAH. These patients usually present with prominent neck or back pain and myelopathic or radicular symptoms that localize to one or more spinal roots [<a href="#rid37">37,38</a>].</p><p>Vascular malformations and aneurysms in the spine can be difficult to visualize with cerebral neuroimaging testing [<a href="#rid8">8,33,34</a>]. Cerebral DSA performed to exclude more common intracranial aneurysms may not identify spinal lesions. The diagnosis may be delayed until the patient presents with recurrent SAH. Acute brain imaging may show SAH that predominates in the caudal areas of the brainstem. However, dedicated spinal DSA is typically required to identify these lesions. Spinal vascular malformations and aneurysms are generally managed by neurosurgical and/or endovascular interventions. (See  <a class="medical medical_review" href="/d/html/5093.html" rel="external">"Disorders affecting the spinal cord", section on 'Vascular malformations'</a>.)</p><p class="headingAnchor" id="H843826022"><span class="h2">Uncommon etiologies</span></p><p class="bulletIndent1"><span class="glyph">●</span>Primary and metastatic brain tumors have been reported to produce SAH as the presenting manifestation [<a href="#rid6">6,39,40</a>]. (See  <a class="medical medical_review" href="/d/html/5180.html" rel="external">"Overview of the clinical features and diagnosis of brain tumors in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Moyamoya disease is associated with cerebral aneurysms that can rupture and produce SAH; however, NASAH may also occur from rupture of the fragile transdural anastomotic vessels [<a href="#rid41">41,42</a>]. (See  <a class="medical medical_review" href="/d/html/1131.html" rel="external">"Moyamoya disease and moyamoya syndrome: Etiology, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pituitary apoplexy often presents with sudden onset of headache and vomiting, and there can be prominent subarachnoid blood on head CT, which may obscure visualization of the pituitary adenoma [<a href="#rid43">43-46</a>]. Pituitary apoplexy is usually heralded by vision change and is accompanied by oculomotor nerve palsies. If not identified on the initial CT scan, brain MRI with dedicated pituitary sequences should be performed [<a href="#rid47">47,48</a>]. (See  <a class="medical medical_review" href="/d/html/6636.html" rel="external">"Causes of hypopituitarism", section on 'Pituitary apoplexy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Spontaneous intracranial hypotension may present with orthostatic headache and NASAH, typically in the setting of acute worsening of symptoms [<a href="#rid49">49,50</a>]. Diagnosis of spontaneous intracranial hypotension is typically by brain MRI or myelography. (See  <a class="medical medical_review" href="/d/html/3359.html" rel="external">"Spontaneous intracranial hypotension: Pathophysiology, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cerebral vasculitis frequently presents with headache and progressive neurologic symptoms. Acute presentations including ischemic stroke with or without convexity SAH may also occur [<a href="#rid51">51</a>]. (See  <a class="medical medical_review" href="/d/html/8230.html" rel="external">"Primary angiitis of the central nervous system in adults"</a> and  <a class="medical medical_review" href="/d/html/8226.html" rel="external">"Overview of and approach to the vasculitides in adults"</a> and  <a class="medical medical_review" href="/d/html/8237.html" rel="external">"Clinical manifestations and diagnosis of rheumatoid vasculitis", section on 'Neurologic disease'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cerebral hyperperfusion syndrome after carotid endarterectomy or angioplasty with or without stenting and reversible posterior leukoencephalopathy syndrome typically presents with neurologic symptoms due to focal cerebral edema and disruption of the blood-brain barrier, the latter of which may produce convexity SAH [<a href="#rid25">25,28,52-55</a>]. (See  <a class="medical medical_review" href="/d/html/15843.html" rel="external">"Complications of carotid endarterectomy", section on 'Hyperperfusion syndrome'</a> and  <a class="medical medical_review" href="/d/html/4835.html" rel="external">"Reversible posterior leukoencephalopathy syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Several infectious agents that may cause meningitis or meningoencephalitis may also present with SAH. These include several bacterial sources (eg, <em>Streptococcus pneumoniae, Staphylococcus aureus, Neisseria meningitidis, Haemophilus influenzae, Listeria monocytogenes</em>), viruses (eg, herpes zoster), and fungi (eg, <em>Aspergillus</em> and <em>Coccidioides</em> species) [<a href="#rid56">56-60</a>].</p><p></p><p class="headingAnchor" id="H9"><span class="h2">Other associated conditions</span><span class="headingEndMark"> — </span>For many patients with NASAH, diagnostic evaluation may not definitively identify the underlying cause. However, some conditions that have been associated with multiple forms of intracranial hemorrhage, including NASAH, may be attributed as the source of bleeding after excluding other causes. (See <a class="local">'Diagnostic evaluation'</a> below.)</p><p class="bulletIndent1"><span class="glyph">●</span>Sickle cell disease can be complicated by subarachnoid as well as intracerebral hemorrhage [<a href="#rid5">5,8,61</a>]. Most reported cases occur in children with an established diagnosis. These children are often found to have one or more aneurysms; in some cases, SAH is believed to result from fragile collateral blood vessels. Recent transfusion and treatment with glucocorticoids may be risk factors. (See  <a class="medical medical_review" href="/d/html/5926.html" rel="external">"Acute stroke (ischemic and hemorrhagic) in children and adults with sickle cell disease", section on 'Intracranial hemorrhage management'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bleeding disorders can be complicated by NASAH. These include conditions such as disseminated intravascular coagulation or hemophilia and anticoagulant or thrombolytic therapy [<a href="#rid3">3,8,29,62-65</a>]. However, hematologic conditions more frequently present with subdural or intracerebral hemorrhage than with isolated NASAH. Patients with NASAH due to hematologic conditions frequently also present with evidence of systemic bleeding. However, extensive isolated NASAH attributed to reduced platelet activity has been reported in one case series [<a href="#rid66">66</a>]. In general, patients with isolated NASAH and an associated bleeding disorder should be evaluated for an underlying aneurysm or other vascular lesion. (See  <a class="medical medical_review" href="/d/html/1114.html" rel="external">"Perimesencephalic nonaneurysmal subarachnoid hemorrhage"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cocaine and other sympathomimetic substances have been associated with both aneurysmal SAH and NASAH [<a href="#rid6">6,8,67-69</a>]. The mechanism of bleeding in NASAH is not known but may be related to acute blood pressure surges and/or an underlying hypertensive or toxic vasculopathy [<a href="#rid8">8,70</a>]. Patients with SAH and cocaine abuse should be assumed to have an underlying aneurysm or other vascular lesion until proven otherwise. (See  <a class="medical medical_review" href="/d/html/4953.html" rel="external">"Clinical manifestations, diagnosis, and management of the cardiovascular complications of cocaine abuse", section on 'Stroke'</a>.)</p><p></p><p class="headingAnchor" id="H109870614"><span class="h1">CLINICAL PRESENTATION</span><span class="headingEndMark"> — </span>The clinical presentation of NASAH varies by location and extent of the subarachnoid bleeding. Diffuse NASAH may mimic clinical features of aneurysmal SAH. Such patients frequently present with a sudden-onset severe (thunderclap) headache, sometimes associated with transient loss of consciousness, vomiting, or neck pain. (See  <a class="medical medical_review" href="/d/html/1130.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Clinical manifestations and diagnosis", section on 'Clinical presentation'</a>.)</p><p>Isolated SAH over the convexity may manifest with transient motor or sensory symptoms corresponding to underlying brain tissue. Symptoms may evolve over seconds to minutes, similar to focal epileptic phenomena and/or seizures [<a href="#rid28">28</a>]. (See  <a class="medical medical_review" href="/d/html/1128.html" rel="external">"Cerebral amyloid angiopathy", section on 'Transient focal neurologic episodes'</a>.)</p><p class="headingAnchor" id="H10"><span class="h1">DIAGNOSTIC EVALUATION</span><span class="headingEndMark"> — </span>SAH should be considered in any patient complaining of a severe headache of sudden onset. Initial evaluation of patients suspected of having SAH includes urgent head CT [<a href="#rid29">29</a>]. If the CT scan fails to show blood in subarachnoid space, a lumbar puncture must be obtained. Additional details on the diagnosis of SAH are discussed separately. (See  <a class="medical medical_review" href="/d/html/1130.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Clinical manifestations and diagnosis", section on 'Evaluation and diagnosis'</a>.)</p><p>Imaging evaluation for underlying causes of bleeding is performed to identify or exclude etiologies that require specific treatment, to prevent complications, and to minimize morbidity.</p><p class="headingAnchor" id="H818851672"><span class="h2">Assess pattern of acute bleeding</span><span class="headingEndMark"> — </span>The selection of initial imaging to identify the cause of bleeding generally varies by the distribution of SAH found on initial head CT  (<a class="graphic graphic_diagnosticimage graphicRef121315" href="/d/graphic/121315.html" rel="external">image 2</a> and <a class="graphic graphic_algorithm graphicRef140106" href="/d/graphic/140106.html" rel="external">algorithm 1</a>).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Aneurysmal SAH pattern</strong> – Aneurysmal SAH pattern located in the basal cisterns, in the Sylvian or interhemispheric fissures, or diffusely <strong>require</strong> initial angiographic evaluation to exclude a ruptured cerebral aneurysm as the cause of bleeding. Further testing is performed if angiographic evaluation has not identified an aneurysm or other vascular cause to bleeding. (See <a class="local">'Evaluation for patients with aneurysmal pattern of bleeding'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Convexity SAH</strong> – SAH that is isolated to the convexities of the cerebral hemispheres may be due to one of several causes; the evaluation will vary by clinical circumstance. (See <a class="local">'Evaluation for patients with isolated convexity SAH'</a> below.)</p><p></p><p class="headingAnchor" id="H195363296"><span class="h2">Evaluation for patients with aneurysmal pattern of bleeding</span></p><p class="headingAnchor" id="H3659706324"><span class="h3">Initial imaging</span><span class="headingEndMark"> — </span>For patients with an aneurysmal SAH pattern, initial angiographic testing is performed to identify patients with a ruptured cerebral aneurysm as the cause of SAH. Patients with aneurysmal SAH typically require surgical or endovascular treatment and intensive medical care; The goal of such treatment is to reduce the risk of rebleeding and treat complications such as cerebral vasospasm and hydrocephalus; all of these are associated with significant morbidity and mortality. (See  <a class="medical medical_review" href="/d/html/1127.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Treatment and prognosis"</a>.)</p><p>Initial angiographic testing may also identify other vascular etiologies such as a vascular malformation or intracranial dissection. (See <a class="local">'Etiologies'</a> above.)</p><p class="headingAnchor" id="H11"><span class="h4">Cerebral angiography</span><span class="headingEndMark"> — </span>Digital subtraction angiography (DSA) is the most sensitive and preferred imaging modality to assess for cerebral aneurysm. DSA should include demonstration of key arterial branch points, including the proximal posterior circulation, to effectively assess for cerebral aneurysms. In addition, injections of the external carotid and vertebral circulations and deep cervical branches may be helpful to identify other vascular causes such as a dural arteriovenous fistula or a vascular malformation in the cervical spine. (See  <a class="medical medical_review" href="/d/html/1130.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Clinical manifestations and diagnosis"</a>.)</p><p class="headingAnchor" id="H1451973651"><span class="h4">Alternative options</span><span class="headingEndMark"> — </span>Noninvasive testing with CT angiography (CTA) or magnetic resonance angiography (MRA) of the head may be used as an alternative initial angiographic test to identify suspected cerebral aneurysms or other vascular lesions. A major advantage of CTA over DSA is the speed and ease with which it can be obtained, often immediately after the diagnosis of SAH is made by head CT, when the patient is still in the scanner. In this setting, CTA is a more practical approach to acute diagnosis than MRA, given the constraints of acute patient management. Noninvasive testing may avoid the need for conventional angiography in some patients [<a href="#rid71">71-73</a>].</p><p>CTA may be more sensitive for aneurysm detection than MRA [<a href="#rid74">74</a>]. However, CTA or MRA has imperfect sensitivity for the detection of cerebral aneurysms, particularly small aneurysms [<a href="#rid73">73</a>]. Even when an aneurysm is identified by noninvasive techniques, DSA may also be performed to exclude multiple aneurysms and to plan surgical intervention [<a href="#rid75">75</a>].</p><p class="headingAnchor" id="H346837897"><span class="h3">Subsequent testing when cerebral angiography is negative</span><span class="headingEndMark"> — </span>Additional testing to identify nonaneurysmal causes of bleeding should be performed when the underlying cause is uncertain despite initial angiographic evaluation.</p><p class="headingAnchor" id="H1644078575"><span class="h4">Patients with perimesencephalic SAH</span><span class="headingEndMark"> — </span>Additional imaging may be <strong>unnecessary</strong> for stable patients when initial DSA has excluded a cerebral aneurysm and the pattern of bleeding is consistent with a perimesencephalic SAH  (<a class="graphic graphic_diagnosticimage graphicRef118108" href="/d/graphic/118108.html" rel="external">image 3</a>). Patients with a perimesencephalic pattern to SAH and a negative initial DSA have a low likelihood of having an aneurysmal cause of bleeding [<a href="#rid2">2,76</a>]. However, some patients with a perimesencephalic SAH may warrant repeat cerebral DSA or noninvasive CT angiography if the initial study was felt to be technically inadequate or if rebleeding occurs.</p><p>The imaging evaluation for perimesencephalic SAH is discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/1114.html" rel="external">"Perimesencephalic nonaneurysmal subarachnoid hemorrhage"</a>.)</p><p class="headingAnchor" id="H2383584929"><span class="h4">Other patients</span><span class="headingEndMark"> — </span>Patients with an aneurysmal SAH pattern that is atypical for perimesencephalic SAH <strong>require</strong> additional imaging when initial angiography is unrevealing and the cause of bleeding is uncertain.</p><p class="headingAnchor" id="H34860325"><span class="h5">Magnetic resonance imaging</span><span class="headingEndMark"> — </span>We perform gadolinium-enhanced magnetic resonance imaging (MRI) of the brain for patients with an uncertain cause to SAH after angiographic evaluation [<a href="#rid6">6,32,77</a>]. We also perform MRI of the spine for such patients with bleeding concentrated in the cervicomedullary regions. MRI with gadolinium may demonstrate angiographically occult lesions that can cause NASAH, including some vascular malformations in the brain or spinal cord, tumors (eg, pituitary adenoma), and intracranial arterial dissections [<a href="#rid36">36,78</a>]. Head and spinal CT with contrast can be performed as less sensitive alternative tests for patients unable to undergo MRI.</p><p>Delayed repeat brain MRI may be performed for selected patients after blood has resorbed (eg, six to eight weeks after SAH) if the initial study was limited by the presence and extent of acute bleeding.</p><p class="headingAnchor" id="H3162026177"><span class="h5">The role of repeat cerebral angiography</span><span class="headingEndMark"> — </span>For patients with an aneurysmal pattern SAH with an uncertain cause to symptoms despite initial cerebral DSA and MRI, we typically repeat DSA within 4 to 14 days after an initial negative study. However, the optimal timing of this study is unclear and should be individualized according to the patient's condition and presence of other complications. In reported case series, the repeat DSA has been performed at a follow-up interval between four days and four weeks [<a href="#rid5">5,6,8,13,76,79-82</a>].</p><p>Some patients with initial negative angiography are found to have an aneurysm on repeat angiography, at rates ranging from 3 to 24 percent in case series [<a href="#rid5">5,6,8,13,76,83,84</a>]. Rates as high as 49 percent have been reported for series of patients that exclude those with perimesencephalic NASAH and others with normal initial head CT [<a href="#rid5">5,76,79</a>]. Reasons for an initial false-negative angiogram include technical or reading errors, small aneurysm size, and obscuration of the aneurysm because of vasospasm, hematoma, or thrombosis within the aneurysm.</p><p>A repeat study may also reveal an arterial dissection or a vascular malformation not identified on the initial study [<a href="#rid33">33,34,85</a>].</p><p>The value of additional angiographic testing to identify a cerebral aneurysm following two negative angiograms is uncertain [<a href="#rid1">1,8,85</a>]. We generally reserve further angiographic testing for patients with technically inadequate initial studies or if rebleeding occurs. Some older case series identified aneurysmal cause to SAH on a third angiogram or by surgical exploration [<a href="#rid6">6,84</a>], but others have reported no additional benefit with a third DSA [<a href="#rid85">85</a>]. While in some cases surgical exploration was prompted by an episode of rebleeding or a suspicious but nondiagnostic finding on angiography, in other cases it is not always certain why surgical exploration was performed.</p><p class="headingAnchor" id="H14"><span class="h5">Spinal angiography</span><span class="headingEndMark"> — </span>Spinal angiography may be performed for some patients with NASAH and an unclear cause despite prior imaging [<a href="#rid33">33-36</a>]. This includes those with prominent back or neck pain, radicular or myelopathic features on examination, or abnormal but nondiagnostic findings on other neuroimaging studies. (See  <a class="medical medical_review" href="/d/html/5093.html" rel="external">"Disorders affecting the spinal cord", section on 'Vascular malformations'</a>.)</p><p class="headingAnchor" id="H1328175729"><span class="h2">Evaluation for patients with isolated convexity SAH</span><span class="headingEndMark"> — </span>Nontraumatic convexity SAH is associated with a diverse group of etiologies. These include:</p><p class="bulletIndent1"><span class="glyph">●</span>Cerebral amyloid angiopathy (see  <a class="medical medical_review" href="/d/html/1128.html" rel="external">"Cerebral amyloid angiopathy"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Reversible cerebral vasoconstriction syndrome (see  <a class="medical medical_review" href="/d/html/14075.html" rel="external">"Reversible cerebral vasoconstriction syndrome"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Cerebral venous thrombosis (see  <a class="medical medical_review" href="/d/html/1103.html" rel="external">"Cerebral venous thrombosis: Etiology, clinical features, and diagnosis"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Mycotic aneurysm from infective endocarditis (see  <a class="medical medical_review" href="/d/html/2129.html" rel="external">"Overview of infected (mycotic) arterial aneurysm"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Hemorrhagic cerebral tumor (see  <a class="medical medical_review" href="/d/html/5180.html" rel="external">"Overview of the clinical features and diagnosis of brain tumors in adults"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Intracranial dissection (see  <a class="medical medical_review" href="/d/html/14082.html" rel="external">"Cerebral and cervical artery dissection: Clinical features and diagnosis"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Vascular malformation (see  <a class="medical medical_review" href="/d/html/1129.html" rel="external">"Vascular malformations of the central nervous system"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Cerebral vasculitis (see  <a class="medical medical_review" href="/d/html/8230.html" rel="external">"Primary angiitis of the central nervous system in adults"</a>)</p><p></p><p>The initial diagnostic imaging test to identify the underlying cause of isolated convexity SAH varies by clinical features  (<a class="graphic graphic_table graphicRef140108" href="/d/graphic/140108.html" rel="external">table 1</a>). As examples, for an 80-year-old patient presenting with transient motor deficit and head CT showing acute convexity SAH, brain MRI with T2*-weighted susceptibility-weighted sequences may be performed as an initial diagnostic test to assess for cerebral amyloid angiopathy (CAA). For a patient presenting with multiple episodes of thunderclap headache over the preceding several days, CTA of the head may be performed to assess for reversible cerebral vasoconstriction syndrome (RCVS).</p><p>The causes of convexity SAH are typically nonaneurysmal [<a href="#rid77">77,86,87</a>]. However, angiographic evaluation to exclude ruptured cerebral aneurysm is warranted when SAH in the hemispheric convexities is accompanied by bleeding in the basal cisterns or Sylvian or interhemispheric fissures or is diffuse. In addition, angiographic evaluation may be warranted when the initial diagnostic imaging test does not identify the cause of convexity SAH. (See <a class="local">'Initial imaging'</a> above.)</p><p class="headingAnchor" id="H16"><span class="h1">MANAGEMENT AND PROGNOSIS</span><span class="headingEndMark"> — </span>The approach to the general care and initial monitoring of patients with NASAH is the same as that for patients with aneurysmal SAH. Patients with extensive or diffuse NASAH may have a complicated course similar to patients with aneurysmal SAH, including risks of developing hydrocephalus or vasospasm [<a href="#rid88">88</a>]. However, other patients with NASAH presenting with a small amount of focal subarachnoid bleeding and mild symptoms may remain clinically stable and have a more benign course.</p><p class="headingAnchor" id="H4213430664"><span class="h2">Supportive care</span><span class="headingEndMark"> — </span>All patients with SAH should be admitted to a facility with neurologic and/or neurosurgical expertise to assess for underlying causes of bleeding and to monitor for complications of SAH. Patients with disabling neurologic symptoms such as hemiparesis or stupor or those with diffuse SAH should be admitted to an intensive care setting at a facility with neurologic and neurosurgical expertise to manage hemodynamic status and monitor for neurologic deterioration.</p><p>Specific acute supportive care strategies for patients with NASAH include blood pressure control, reversal of anticoagulation, deep venous thrombosis prophylaxis, and pain control. These issues are described in detail separately. (See  <a class="medical medical_review" href="/d/html/1127.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Treatment and prognosis", section on 'Acute care'</a>.)</p><p class="headingAnchor" id="H3412100223"><span class="h2">Complications</span><span class="headingEndMark"> — </span>Patients with NASAH may develop complications associated with aneurysmal SAH [<a href="#rid89">89</a>]. These include:</p><p class="bulletIndent1"><span class="glyph">●</span>Rebleeding</p><p class="bulletIndent1"><span class="glyph">●</span>Vasospasm and cerebral ischemia</p><p class="bulletIndent1"><span class="glyph">●</span>Hydrocephalus</p><p class="bulletIndent1"><span class="glyph">●</span>Increased intracranial pressure</p><p class="bulletIndent1"><span class="glyph">●</span>Seizures</p><p class="bulletIndent1"><span class="glyph">●</span>Hyponatremia</p><p class="bulletIndent1"><span class="glyph">●</span>Cardiac abnormalities</p><p></p><p>There is little specific information about the incidence or severity of these complications in NASAH in comparison with aneurysmal SAH. The risk of rebleeding depends on the underlying etiology of SAH. The risks of other complications likely vary according to the extent and location of bleeding. Patients with perimesencephalic SAH appear to have lower risk of complications than patients with NASAH due to other etiologies [<a href="#rid7">7,90,91</a>].</p><p>In a retrospective single-center review of 138 patients with NASAH, vasospasm occurred in nearly 20 percent of those with diffuse SAH, similar to matched historical controls and higher than those with a perimesencephalic pattern of SAH [<a href="#rid89">89</a>].</p><p>Shunt-dependent hydrocephalus occurred in 14 percent of patients with NASAH in one retrospective series [<a href="#rid92">92</a>]. Associated risk factors included acute hydrocephalus, intraventricular hemorrhage, clinical vasospasm, and anticoagulation medication prior to SAH. Patients should receive other interventions to monitor, prevent, and treat complications of SAH. These are discussed separately. (See  <a class="medical medical_review" href="/d/html/1127.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Treatment and prognosis", section on 'Critical care management'</a> and  <a class="medical medical_review" href="/d/html/1127.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Treatment and prognosis", section on 'Early complications'</a> and  <a class="medical medical_review" href="/d/html/1127.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Treatment and prognosis", section on 'Vasospasm and delayed cerebral ischemia'</a>.)</p><p>The clinical features and management of complications of SAH are discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/1130.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Clinical manifestations and diagnosis", section on 'Complications'</a>.)</p><p class="headingAnchor" id="H1804890849"><span class="h2">Interventions</span><span class="headingEndMark"> — </span>Interventions to prevent rebleeding and other etiologic-specific complications are individualized to the underlying etiology. (See <a class="local">'Etiologies'</a> above.)</p><p class="headingAnchor" id="H3341022910"><span class="h2">Prognosis</span><span class="headingEndMark"> — </span>In general, the prognosis for patients with NASAH is better than the prognosis for those with aneurysmal hemorrhage; however, NASAH represents a heterogenous group of patients and etiologies, and outcomes are largely dependent on the underlying cause and comorbidities [<a href="#rid93">93,94</a>]. (See <a class="local">'Etiologies'</a> above.)</p><p class="headingAnchor" id="H1765256487"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/105370.html" rel="external">"Society guideline links: Stroke in adults"</a>.)</p><p class="headingAnchor" id="H24091180"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/17180.html" rel="external">"Patient education: Subarachnoid hemorrhage (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H17"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – Approximately 20 percent of SAH cases are due to a cause other than a ruptured intracranial aneurysm. There are several potential causes of NASAH, and in some cases, the source of bleeding is not identified. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiologies</strong> – Underlying causes of spontaneous NASAH vary by clinical circumstances and location of bleeding. Common causes include (see <a class="local">'Etiologies'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Perimesencephalic NASAH</p><p class="bulletIndent2"><span class="glyph">•</span>Cerebral vascular malformations</p><p class="bulletIndent2"><span class="glyph">•</span>Intracranial arterial dissection</p><p class="bulletIndent2"><span class="glyph">•</span>Reversible cerebral vasoconstriction syndrome</p><p class="bulletIndent2"><span class="glyph">•</span>Cerebral venous thrombosis</p><p class="bulletIndent2"><span class="glyph">•</span>Cerebral amyloid angiopathy</p><p class="bulletIndent2"><span class="glyph">•</span>Minor or unsuspected trauma</p><p class="bulletIndent2"><span class="glyph">•</span>Spinal causes, such as vascular malformation, aneurysm, or tumor</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – The clinical presentation of NASAH varies by location and extent of the subarachnoid bleeding. Diffuse NASAH may mimic clinical features of aneurysmal SAH. Isolated SAH over the convexity may manifest with transient motor or sensory symptoms corresponding to underlying brain tissue. (See <a class="local">'Clinical presentation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation for underlying cause</strong> – Imaging evaluation for underlying causes of bleeding is performed to identify or exclude etiologies that require specific treatment, to prevent complications, and to minimize morbidity. The selection of initial imaging testing varies by the distribution of SAH found on initial head CT  (<a class="graphic graphic_diagnosticimage graphicRef121315" href="/d/graphic/121315.html" rel="external">image 2</a>). (See <a class="local">'Diagnostic evaluation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Evaluation for patients with an aneurysmal SAH pattern</strong> – Aneurysmal SAH pattern located in the basal cisterns, in the Sylvian or interhemispheric fissures, or diffusely <strong>require </strong>initial angiographic evaluation to exclude a ruptured cerebral aneurysm as the cause of bleeding  (<a class="graphic graphic_algorithm graphicRef140106" href="/d/graphic/140106.html" rel="external">algorithm 1</a>). (See <a class="local">'Evaluation for patients with aneurysmal pattern of bleeding'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Initial angiographic imaging</strong> – We prefer digital subtraction angiography (DSA) to assess for cerebral aneurysm because it is more sensitive than noninvasive imaging modalities. Angiography may also identify other vascular etiologies such as a vascular malformation or intracranial dissection. (See <a class="local">'Initial imaging'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Subsequent testing</strong> – Patients with an aneurysmal SAH pattern that is atypical for perimesencephalic SAH <strong>require</strong> additional imaging when initial angiography is unrevealing and the cause of bleeding is uncertain. Further diagnostic imaging typically includes MRI of the brain with contrast and repeat cerebral DSA. (See <a class="local">'Subsequent testing when cerebral angiography is negative'</a> above.)</p><p></p><p class="bulletIndent3">Some patients with a perimesencephalic SAH may warrant repeat cerebral DSA or noninvasive CT angiography if the initial study was felt to be technically inadequate or if rebleeding occurs. (See <a class="local">'Patients with perimesencephalic SAH'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Evaluation for patients with isolated convexity SAH</strong> – The evaluation of SAH that is isolated to the convexities of the cerebral hemispheres may be due to several causes and varies by clinical circumstances  (<a class="graphic graphic_table graphicRef140108" href="/d/graphic/140108.html" rel="external">table 1</a>). (See <a class="local">'Evaluation for patients with isolated convexity SAH'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – The approach to the general care and initial monitoring of patients with NASAH is the same as that for patients with aneurysmal SAH. (See <a class="local">'Management and prognosis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Supportive care</strong> – All patients with SAH should be admitted to a facility with neurologic and/or neurosurgical expertise. Those with disabling neurologic symptoms or diffuse SAH should be admitted to an intensive care setting with the expertise to manage hemodynamic status and monitor for neurologic deterioration. (See <a class="local">'Supportive care'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Complications</strong> – Patients with NASAH may develop complications associated with aneurysmal SAH including hydrocephalus, vasospasm and cerebral ischemia, seizures, hyponatremia, and cardiac abnormalities. (See  <a class="medical medical_review" href="/d/html/1127.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Treatment and prognosis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Interventions</strong> – Interventions to prevent rebleeding and other etiologic-specific complications are individualized to the underlying etiology. (See <a class="local">'Interventions'</a> above.)</p><p></p><p class="headingAnchor" id="H97789572"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges David Brock, MD, CIP, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Rinkel GJ, Wijdicks EF, Hasan D, et al. Outcome in patients with subarachnoid haemorrhage and negative angiography according to pattern of haemorrhage on computed tomography. Lancet 1991; 338:964.</a></li><li><a class="nounderline abstract_t">van Gijn J, van Dongen KJ, Vermeulen M, Hijdra A. Perimesencephalic hemorrhage: a nonaneurysmal and benign form of subarachnoid hemorrhage. Neurology 1985; 35:493.</a></li><li><a class="nounderline abstract_t">Canhão P, Ferro JM, Pinto AN, et al. Perimesencephalic and nonperimesencephalic subarachnoid haemorrhages with negative angiograms. Acta Neurochir (Wien) 1995; 132:14.</a></li><li><a class="nounderline abstract_t">Rinkel GJ, Wijdicks EF, Vermeulen M, et al. Nonaneurysmal perimesencephalic subarachnoid hemorrhage: CT and MR patterns that differ from aneurysmal rupture. AJNR Am J Neuroradiol 1991; 12:829.</a></li><li><a class="nounderline abstract_t">Schwartz TH, Solomon RA. Perimesencephalic nonaneurysmal subarachnoid hemorrhage: review of the literature. Neurosurgery 1996; 39:433.</a></li><li><a class="nounderline abstract_t">Tatter SB, Crowell RM, Ogilvy CS. Aneurysmal and microaneurysmal "angiogram-negative" subarachnoid hemorrhage. Neurosurgery 1995; 37:48.</a></li><li><a class="nounderline abstract_t">Ildan F, Tuna M, Erman T, et al. Prognosis and prognostic factors in nonaneurysmal perimesencephalic hemorrhage: a follow-up study in 29 patients. Surg Neurol 2002; 57:160.</a></li><li><a class="nounderline abstract_t">Rinkel GJ, van Gijn J, Wijdicks EF. Subarachnoid hemorrhage without detectable aneurysm. A review of the causes. Stroke 1993; 24:1403.</a></li><li><a class="nounderline abstract_t">Cordonnier C, Al-Shahi Salman R, Bhattacharya JJ, et al. Differences between intracranial vascular malformation types in the characteristics of their presenting haemorrhages: prospective, population-based study. J Neurol Neurosurg Psychiatry 2008; 79:47.</a></li><li><a class="nounderline abstract_t">Halbach VV, Higashida RT, Hieshima GB, et al. Dural fistulas involving the transverse and sigmoid sinuses: results of treatment in 28 patients. Radiology 1987; 163:443.</a></li><li><a class="nounderline abstract_t">Bikmaz K, Erdem E, Krisht A. Arteriovenous fistula originating from proximal part of the anterior cerebral artery. Clin Neurol Neurosurg 2007; 109:589.</a></li><li><a class="nounderline abstract_t">Duffau H, Lopes M, Janosevic V, et al. Early rebleeding from intracranial dural arteriovenous fistulas: report of 20 cases and review of the literature. J Neurosurg 1999; 90:78.</a></li><li><a class="nounderline abstract_t">du Mesnil de Rochemont R, Heindel W, Wesselmann C, et al. Nontraumatic subarachnoid hemorrhage: value of repeat angiography. Radiology 1997; 202:798.</a></li><li><a class="nounderline abstract_t">Brown RD Jr, Wiebers DO, Torner JC, O'Fallon WM. Frequency of intracranial hemorrhage as a presenting symptom and subtype analysis: a population-based study of intracranial vascular malformations in Olmsted Country, Minnesota. J Neurosurg 1996; 85:29.</a></li><li><a class="nounderline abstract_t">Caplan LR. Dissections of brain-supplying arteries. Nat Clin Pract Neurol 2008; 4:34.</a></li><li><a class="nounderline abstract_t">Sasaki O, Ogawa H, Koike T, et al. A clinicopathological study of dissecting aneurysms of the intracranial vertebral artery. J Neurosurg 1991; 75:874.</a></li><li><a class="nounderline abstract_t">Santos-Franco JA, Zenteno M, Lee A. Dissecting aneurysms of the vertebrobasilar system. A comprehensive review on natural history and treatment options. Neurosurg Rev 2008; 31:131.</a></li><li><a class="nounderline abstract_t">Zhao WY, Krings T, Alvarez H, et al. Management of spontaneous haemorrhagic intracranial vertebrobasilar dissection: review of 21 consecutive cases. Acta Neurochir (Wien) 2007; 149:585.</a></li><li><a class="nounderline abstract_t">Singhal AB, Hajj-Ali RA, Topcuoglu MA, et al. Reversible cerebral vasoconstriction syndromes: analysis of 139 cases. Arch Neurol 2011; 68:1005.</a></li><li><a class="nounderline abstract_t">Adaletli I, Sirikci A, Kara B, et al. Cerebral venous sinus thrombosis presenting with excessive subarachnoid hemorrhage in a 14-year-old boy. Emerg Radiol 2005; 12:57.</a></li><li><a class="nounderline abstract_t">Oppenheim C, Domigo V, Gauvrit JY, et al. Subarachnoid hemorrhage as the initial presentation of dural sinus thrombosis. AJNR Am J Neuroradiol 2005; 26:614.</a></li><li><a class="nounderline abstract_t">Chang R, Friedman DP. Isolated cortical venous thrombosis presenting as subarachnoid hemorrhage: a report of three cases. AJNR Am J Neuroradiol 2004; 25:1676.</a></li><li><a class="nounderline abstract_t">Sztajzel R, Coeytaux A, Dehdashti AR, et al. Subarachnoid hemorrhage: a rare presentation of cerebral venous thrombosis. Headache 2001; 41:889.</a></li><li><a class="nounderline abstract_t">Kurosu A, Suzukawa K, Amo M, et al. Perimesencephalic non-aneurysmal subarachnoid hemorrhage caused by cavernous sinus thrombosis: case report. Neurol Med Chir (Tokyo) 2007; 47:258.</a></li><li><a class="nounderline abstract_t">Kumar S, Goddeau RP Jr, Selim MH, et al. Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies. Neurology 2010; 74:893.</a></li><li><a class="nounderline abstract_t">Katoh M, Yoshino M, Asaoka K, et al. A restricted subarachnoid hemorrhage in the cortical sulcus in cerebral amyloid angiopathy: could it be a warning sign? Surg Neurol 2007; 68:457.</a></li><li><a class="nounderline abstract_t">Karabatsou K, Lecky BR, Rainov NG, et al. Cerebral amyloid angiopathy with symptomatic or occult subarachnoid haemorrhage. Eur Neurol 2007; 57:103.</a></li><li><a class="nounderline abstract_t">Beitzke M, Gattringer T, Enzinger C, et al. Clinical presentation, etiology, and long-term prognosis in patients with nontraumatic convexal subarachnoid hemorrhage. Stroke 2011; 42:3055.</a></li><li><a class="nounderline abstract_t">van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: diagnosis, causes and management. Brain 2001; 124:249.</a></li><li><a class="nounderline abstract_t">Caroscio JT, Brannan T, Budabin M, et al. Subarachnoid hemorrhage secondary to spinal arteriovenous malformation and aneurysm. Report of a case and review of the literature. Arch Neurol 1980; 37:101.</a></li><li><a class="nounderline abstract_t">Kandel EI. Complete excision of arteriovenous malformations of the cervical cord. Surg Neurol 1980; 13:135.</a></li><li><a class="nounderline abstract_t">Koch C. Spinal dural arteriovenous fistula. Curr Opin Neurol 2006; 19:69.</a></li><li><a class="nounderline abstract_t">van Beijnum J, Straver DC, Rinkel GJ, Klijn CJ. Spinal arteriovenous shunts presenting as intracranial subarachnoid haemorrhage. J Neurol 2007; 254:1044.</a></li><li><a class="nounderline abstract_t">Aviv RI, Shad A, Tomlinson G, et al. Cervical dural arteriovenous fistulae manifesting as subarachnoid hemorrhage: report of two cases and literature review. AJNR Am J Neuroradiol 2004; 25:854.</a></li><li><a class="nounderline abstract_t">Kinouchi H, Mizoi K, Takahashi A, et al. Dural arteriovenous shunts at the craniocervical junction. J Neurosurg 1998; 89:755.</a></li><li><a class="nounderline abstract_t">Rogg JM, Smeaton S, Doberstein C, et al. Assessment of the value of MR imaging for examining patients with angiographically negative subarachnoid hemorrhage. AJR Am J Roentgenol 1999; 172:201.</a></li><li><a class="nounderline abstract_t">Gonzalez LF, Zabramski JM, Tabrizi P, et al. Spontaneous spinal subarachnoid hemorrhage secondary to spinal aneurysms: diagnosis and treatment paradigm. Neurosurgery 2005; 57:1127.</a></li><li><a class="nounderline abstract_t">Massand MG, Wallace RC, Gonzalez LF, et al. Subarachnoid hemorrhage due to isolated spinal artery aneurysm in four patients. AJNR Am J Neuroradiol 2005; 26:2415.</a></li><li><a class="nounderline abstract_t">Scotti G, Filizzolo F, Scialfa G, et al. Repeated subarachnoid hemorrhages from a cervical meningioma. Case report. J Neurosurg 1987; 66:779.</a></li><li><a class="nounderline abstract_t">Navi BB, Reichman JS, Berlin D, et al. Intracerebral and subarachnoid hemorrhage in patients with cancer. Neurology 2010; 74:494.</a></li><li><a class="nounderline abstract_t">Marushima A, Yanaka K, Matsuki T, et al. Subarachnoid hemorrhage not due to ruptured aneurysm in moyamoya disease. J Clin Neurosci 2006; 13:146.</a></li><li><a class="nounderline abstract_t">Wu H, Song S, Zhang X, Jin Y. Nonaneurysmal subarachnoid hemorrhage and cerebral infarction associated with moyamoya disease. J Craniofac Surg 2014; 25:e358.</a></li><li><a class="nounderline abstract_t">Bjerre P, Videbaek H, Lindholm J. Subarachnoid hemorrhage with normal cerebral angiography: a prospective study on sellar abnormalities and pituitary function. Neurosurgery 1986; 19:1012.</a></li><li><a class="nounderline abstract_t">Wohaibi MA, Russell NA, Ferayan AA, et al. Pituitary apoplexy presenting as massive subarachnoid hemorrhage. J Neurol Neurosurg Psychiatry 2000; 69:700.</a></li><li><a class="nounderline abstract_t">Sergides IG, Minhas PS, Anotun N, Pickard JD. Pituitary apoplexy can mimic subarachnoid haemorrhage clinically and radiologically. Emerg Med J 2007; 24:308.</a></li><li><a class="nounderline abstract_t">Satyarthee GD, Mahapatra AK. Pituitary apoplexy in a child presenting with massive subarachnoid and intraventricular hemorrhage. J Clin Neurosci 2005; 12:94.</a></li><li><a class="nounderline abstract_t">Inamasu J, Hori S, Sekine K, Aikawa N. Pituitary apoplexy without ocular/visual symptoms. Am J Emerg Med 2001; 19:88.</a></li><li><a class="nounderline abstract_t">Hernandez A, Angeles Del Real M, Aguirre M, et al. Pituitary apoplexy: a transient benign presentation mimicking mild subarachnoid hemorrhage with negative angiography. Eur J Neurol 1998; 5:499.</a></li><li><a class="nounderline abstract_t">Cao Y, Na W, Su H, et al. Subarachnoid hemorrhage caused by spontaneous intracranial hypotension: two rare cases report. Int J Neurosci 2023; 133:51.</a></li><li><a class="nounderline abstract_t">Oppo V, Cossu G, Secci S, Melis M. Widening the spectrum of secondary headache: intracranial hypotension following a non-aneurysmal subarachnoid hemorrhage. Neurol Sci 2019; 40:2179.</a></li><li><a class="nounderline abstract_t">André R, Cottin V, Saraux JL, et al. Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Report of 26 patients and review of the literature. Autoimmun Rev 2017; 16:963.</a></li><li><a class="nounderline abstract_t">Ducros A, Boukobza M, Porcher R, et al. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 2007; 130:3091.</a></li><li><a class="nounderline abstract_t">Spitzer C, Mull M, Rohde V, Kosinski CM. Non-traumatic cortical subarachnoid haemorrhage: diagnostic work-up and aetiological background. Neuroradiology 2005; 47:525.</a></li><li><a class="nounderline abstract_t">Muehlschlegel S, Kursun O, Topcuoglu MA, et al. Differentiating reversible cerebral vasoconstriction syndrome with subarachnoid hemorrhage from other causes of subarachnoid hemorrhage. JAMA Neurol 2013; 70:1254.</a></li><li><a class="nounderline abstract_t">Barboza MA, Maud A, Rodriguez GJ. Reversible cerebral vasoconstriction syndrome and nonaneurysmal subarachnoid hemorrhage. J Vasc Interv Neurol 2014; 7:17.</a></li><li><a class="nounderline abstract_t">Deliran SS, Brouwer MC, van de Beek D. Subarachnoid Hemorrhage in Bacterial Meningitis Patients. Cerebrovasc Dis 2022; 51:118.</a></li><li><a class="nounderline abstract_t">Belyamani L, Lakhlit M, Zidouh S. Meningococcus meningitis revealed by a subarachnoid hemorrhage. J Emerg Med 2012; 43:1081.</a></li><li><a class="nounderline abstract_t">Jain R, Deveikis J, Hickenbottom S, Mukherji SK. Varicella-zoster vasculitis presenting with intracranial hemorrhage. AJNR Am J Neuroradiol 2003; 24:971.</a></li><li><a class="nounderline abstract_t">Tsuzaki K, Murakata K, Kamei M, et al. A Case of Invasive Aspergillus Rhinosinusitis Presenting with Unilateral Visual Loss and Subsequently Associated with Meningitis, Subarachnoid Hemorrhage, and Cerebral Infarction. Case Rep Neurol Med 2020; 2020:8885166.</a></li><li><a class="nounderline abstract_t">Singh R, Srinivasan VM, Catapano JS, et al. Coccidioidal meningitis with multiple aneurysms presenting with pseudo-subarachnoid hemorrhage: illustrative case. J Neurosurg Case Lessons 2021; 2:CASE21424.</a></li><li><a class="nounderline abstract_t">Strouse JJ, Hulbert ML, DeBaun MR, et al. Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids. Pediatrics 2006; 118:1916.</a></li><li><a class="nounderline abstract_t">Rogers LR. Cerebrovascular complications in cancer patients. Neurol Clin 2003; 21:167.</a></li><li><a class="nounderline abstract_t">Schwartzman RJ, Hill JB. Neurologic complications of disseminated intravascular coagulation. Neurology 1982; 32:791.</a></li><li><a class="nounderline abstract_t">Alghamdi MA, Almubarak AO, Alsedrani N, et al. Pretruncal Nonaneurysmal Subarachnoid Hemorrhage with Underlying Hemophilia C. World Neurosurg 2019; 127:109.</a></li><li><a class="nounderline abstract_t">Das B, Mahajan A, Goel G, Garg A. Tenecteplase-induced Nonaneurysmal Subarachnoid Hemorrhage in a Patient with Acute Ischemic Stroke: A Case Report and Literature Review. Asian J Neurosurg 2020; 15:706.</a></li><li><a class="nounderline abstract_t">Naidech AM, Rosenberg NF, Maas MB, et al. Predictors of hemorrhage volume and disability after perimesencephalic subarachnoid hemorrhage. Neurology 2012; 78:811.</a></li><li><a class="nounderline abstract_t">Levine SR, Brust JC, Futrell N, et al. A comparative study of the cerebrovascular complications of cocaine: alkaloidal versus hydrochloride--a review. Neurology 1991; 41:1173.</a></li><li><a class="nounderline abstract_t">Nolte KB, Brass LM, Fletterick CF. Intracranial hemorrhage associated with cocaine abuse: a prospective autopsy study. Neurology 1996; 46:1291.</a></li><li><a class="nounderline abstract_t">Huang MC, Yang SY, Lin SK, et al. Risk of Cardiovascular Diseases and Stroke Events in Methamphetamine Users: A 10-Year Follow-Up Study. J Clin Psychiatry 2016; 77:1396.</a></li><li><a class="nounderline abstract_t">Storen EC, Wijdicks EF, Crum BA, Schultz G. Moyamoya-like vasculopathy from cocaine dependency. AJNR Am J Neuroradiol 2000; 21:1008.</a></li><li><a class="nounderline abstract_t">Madureira S, Canhão P, Guerreiro M, Ferro JM. Cognitive and emotional consequences of perimesencephalic subarachnoid hemorrhage. J Neurol 2000; 247:862.</a></li><li><a class="nounderline abstract_t">Marquardt G, Niebauer T, Schick U, Lorenz R. Long term follow up after perimesencephalic subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2000; 69:127.</a></li><li><a class="nounderline abstract_t">Colen TW, Wang LC, Ghodke BV, et al. Effectiveness of MDCT angiography for the detection of intracranial aneurysms in patients with nontraumatic subarchnoid hemorrhage. AJR Am J Roentgenol 2007; 189:898.</a></li><li><a class="nounderline abstract_t">Chen X, Liu Y, Tong H, et al. Meta-analysis of computed tomography angiography versus magnetic resonance angiography for intracranial aneurysm. Medicine (Baltimore) 2018; 97:e10771.</a></li><li><a class="nounderline abstract_t">Hashimoto Y, Kin S, Haraguchi K, Niwa J. Pitfalls in the preoperative evaluation of subarachnoid hemorrhage without digital subtraction angiography: report on 2 cases. Surg Neurol 2007; 68:344.</a></li><li><a class="nounderline abstract_t">Jung JY, Kim YB, Lee JW, et al. Spontaneous subarachnoid haemorrhage with negative initial angiography: a review of 143 cases. J Clin Neurosci 2006; 13:1011.</a></li><li><a class="nounderline abstract_t">Larson AS, Brinjikji W. Subarachnoid Hemorrhage of Unknown Cause: Distribution and Role of Imaging. Neuroimaging Clin N Am 2021; 31:167.</a></li><li><a class="nounderline abstract_t">Wijdicks EF, Schievink WI, Miller GM. MR imaging in pretruncal nonaneurysmal subarachnoid hemorrhage: is it worthwhile? Stroke 1998; 29:2514.</a></li><li><a class="nounderline abstract_t">Urbach H, Zentner J, Solymosi L. The need for repeat angiography in subarachnoid haemorrhage. Neuroradiology 1998; 40:6.</a></li><li><a class="nounderline abstract_t">Bradac GB, Bergui M, Ferrio MF, et al. False-negative angiograms in subarachnoid haemorrhage due to intracranial aneurysms. Neuroradiology 1997; 39:772.</a></li><li><a class="nounderline abstract_t">Duong H, Melançon D, Tampieri D, Ethier R. The negative angiogram in subarachnoid haemorrhage. Neuroradiology 1996; 38:15.</a></li><li><a class="nounderline abstract_t">Inamasu J, Nakamura Y, Saito R, et al. "Occult" ruptured cerebral aneurysms revealed by repeat angiography: result from a large retrospective study. Clin Neurol Neurosurg 2003; 106:33.</a></li><li><a class="nounderline abstract_t">Suzuki S, Kayama T, Sakurai Y, et al. Subarachnoid hemorrhage of unknown cause. Neurosurgery 1987; 21:310.</a></li><li><a class="nounderline abstract_t">Topcuoglu MA, Ogilvy CS, Carter BS, et al. Subarachnoid hemorrhage without evident cause on initial angiography studies: diagnostic yield of subsequent angiography and other neuroimaging tests. J Neurosurg 2003; 98:1235.</a></li><li><a class="nounderline abstract_t">Hashimoto H, Iida J, Hironaka Y, et al. Use of spiral computerized tomography angiography in patients with subarachnoid hemorrhage in whom subtraction angiography did not reveal cerebral aneurysms. J Neurosurg 2000; 92:278.</a></li><li><a class="nounderline abstract_t">Forman R, Conners JJ, Song SY, et al. The Spectrum of Nontraumatic Convexity Subarachnoid Hemorrhage. J Stroke Cerebrovasc Dis 2019; 28:104473.</a></li><li><a class="nounderline abstract_t">Patel KC, Finelli PF. Nonaneurysmal convexity subarachnoid hemorrhage. Neurocrit Care 2006; 4:229.</a></li><li><a class="nounderline abstract_t">Cánovas D, Gil A, Jato M, et al. Clinical outcome of spontaneous non-aneurysmal subarachnoid hemorrhage in 108 patients. Eur J Neurol 2012; 19:457.</a></li><li><a class="nounderline abstract_t">Walcott BP, Stapleton CJ, Koch MJ, Ogilvy CS. Diffuse patterns of nonaneurysmal subarachnoid hemorrhage originating from the Basal cisterns have predictable vasospasm rates similar to aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis 2015; 24:795.</a></li><li><a class="nounderline abstract_t">Coelho LG, Costa JM, Silva EI. Non-aneurysmal spontaneous subarachnoid hemorrhage: perimesencephalic versus non-perimesencephalic. Rev Bras Ter Intensiva 2016; 28:141.</a></li><li><a class="nounderline abstract_t">Hui FK, Tumialán LM, Tanaka T, et al. Clinical differences between angiographically negative, diffuse subarachnoid hemorrhage and perimesencephalic subarachnoid hemorrhage. Neurocrit Care 2009; 11:64.</a></li><li><a class="nounderline abstract_t">Schuss P, Hadjiathanasiou A, Brandecker S, et al. Risk factors for shunt dependency in patients suffering from spontaneous, non-aneurysmal subarachnoid hemorrhage. Neurosurg Rev 2019; 42:139.</a></li><li><a class="nounderline abstract_t">McIntosh AP, Thomas A. Health-Related Quality-of-Life Outcomes: Comparing Patients With Aneurysmal and Nonaneurysmal Subarachnoid Hemorrhage. J Neurosci Nurs 2015; 47:E2.</a></li><li><a class="nounderline abstract_t">Tsermoulas G, Flett L, Gregson B, Mitchell P. Immediate coma and poor outcome in subarachnoid haemorrhage are independently associated with an aneurysmal origin. Clin Neurol Neurosurg 2013; 115:1362.</a></li></ol></div><div id="topicVersionRevision">Topic 1111 Version 24.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1681340" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Outcome in patients with subarachnoid haemorrhage and negative angiography according to pattern of haemorrhage on computed tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3982634" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Perimesencephalic hemorrhage: a nonaneurysmal and benign form of subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7754850" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Perimesencephalic and nonperimesencephalic subarachnoid haemorrhages with negative angiograms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1950905" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Nonaneurysmal perimesencephalic subarachnoid hemorrhage: CT and MR patterns that differ from aneurysmal rupture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8875472" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Perimesencephalic nonaneurysmal subarachnoid hemorrhage: review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8587690" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Aneurysmal and microaneurysmal "angiogram-negative" subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12009538" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Prognosis and prognostic factors in nonaneurysmal perimesencephalic hemorrhage: a follow-up study in 29 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8362440" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Subarachnoid hemorrhage without detectable aneurysm. A review of the causes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17488785" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Differences between intracranial vascular malformation types in the characteristics of their presenting haemorrhages: prospective, population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3562824" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Dural fistulas involving the transverse and sigmoid sinuses: results of treatment in 28 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17544573" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Arteriovenous fistula originating from proximal part of the anterior cerebral artery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10413159" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Early rebleeding from intracranial dural arteriovenous fistulas: report of 20 cases and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9051036" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Nontraumatic subarachnoid hemorrhage: value of repeat angiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8683279" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Frequency of intracranial hemorrhage as a presenting symptom and subtype analysis: a population-based study of intracranial vascular malformations in Olmsted Country, Minnesota.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18199995" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Dissections of brain-supplying arteries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1941116" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : A clinicopathological study of dissecting aneurysms of the intracranial vertebral artery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18309525" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Dissecting aneurysms of the vertebrobasilar system. A comprehensive review on natural history and treatment options.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17514349" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Management of spontaneous haemorrhagic intracranial vertebrobasilar dissection: review of 21 consecutive cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21482916" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Reversible cerebral vasoconstriction syndromes: analysis of 139 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16328476" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Cerebral venous sinus thrombosis presenting with excessive subarachnoid hemorrhage in a 14-year-old boy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15760875" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Subarachnoid hemorrhage as the initial presentation of dural sinus thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15569729" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Isolated cortical venous thrombosis presenting as subarachnoid hemorrhage: a report of three cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11703476" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Subarachnoid hemorrhage: a rare presentation of cerebral venous thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17587777" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Perimesencephalic non-aneurysmal subarachnoid hemorrhage caused by cavernous sinus thrombosis: case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20231664" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17905074" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : A restricted subarachnoid hemorrhage in the cortical sulcus in cerebral amyloid angiopathy: could it be a warning sign?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17179713" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Cerebral amyloid angiopathy with symptomatic or occult subarachnoid haemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21921284" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Clinical presentation, etiology, and long-term prognosis in patients with nontraumatic convexal subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11157554" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Subarachnoid haemorrhage: diagnosis, causes and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7356401" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Subarachnoid hemorrhage secondary to spinal arteriovenous malformation and aneurysm. Report of a case and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7355376" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Complete excision of arteriovenous malformations of the cervical cord.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16415680" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Spinal dural arteriovenous fistula.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17401739" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Spinal arteriovenous shunts presenting as intracranial subarachnoid haemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15140735" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Cervical dural arteriovenous fistulae manifesting as subarachnoid hemorrhage: report of two cases and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9817413" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Dural arteriovenous shunts at the craniocervical junction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9888768" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Assessment of the value of MR imaging for examining patients with angiographically negative subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16331160" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Spontaneous spinal subarachnoid hemorrhage secondary to spinal aneurysms: diagnosis and treatment paradigm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16219857" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Subarachnoid hemorrhage due to isolated spinal artery aneurysm in four patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3572505" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Repeated subarachnoid hemorrhages from a cervical meningioma. Case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20142616" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Intracerebral and subarachnoid hemorrhage in patients with cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16410219" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Subarachnoid hemorrhage not due to ruptured aneurysm in moyamoya disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25006946" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Nonaneurysmal subarachnoid hemorrhage and cerebral infarction associated with moyamoya disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3808231" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Subarachnoid hemorrhage with normal cerebral angiography: a prospective study on sellar abnormalities and pituitary function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11032640" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Pituitary apoplexy presenting as massive subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17384396" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Pituitary apoplexy can mimic subarachnoid haemorrhage clinically and radiologically.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15639425" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Pituitary apoplexy in a child presenting with massive subarachnoid and intraventricular hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11146033" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Pituitary apoplexy without ocular/visual symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10210880" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Pituitary apoplexy: a transient benign presentation mimicking mild subarachnoid hemorrhage with negative angiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33499724" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Subarachnoid hemorrhage caused by spontaneous intracranial hypotension: two rare cases report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30847675" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Widening the spectrum of secondary headache: intracranial hypotension following a non-aneurysmal subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28709761" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Report of 26 patients and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18025032" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15971064" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Non-traumatic cortical subarachnoid haemorrhage: diagnostic work-up and aetiological background.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23939614" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Differentiating reversible cerebral vasoconstriction syndrome with subarachnoid hemorrhage from other causes of subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25132905" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Reversible cerebral vasoconstriction syndrome and nonaneurysmal subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34515065" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Subarachnoid Hemorrhage in Bacterial Meningitis Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22698824" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Meningococcus meningitis revealed by a subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12748105" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Varicella-zoster vasculitis presenting with intracranial hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32963858" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : A Case of Invasive Aspergillus Rhinosinusitis Presenting with Unilateral Visual Loss and Subsequently Associated with Meningitis, Subarachnoid Hemorrhage, and Cerebral Infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35855060" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Coccidioidal meningitis with multiple aneurysms presenting with pseudo-subarachnoid hemorrhage: illustrative case.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17079562" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12690649" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Cerebrovascular complications in cancer patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7201575" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Neurologic complications of disseminated intravascular coagulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30954739" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Pretruncal Nonaneurysmal Subarachnoid Hemorrhage with Underlying Hemophilia C.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33145234" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Tenecteplase-induced Nonaneurysmal Subarachnoid Hemorrhage in a Patient with Acute Ischemic Stroke: A Case Report and Literature Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22377811" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Predictors of hemorrhage volume and disability after perimesencephalic subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1866000" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : A comparative study of the cerebrovascular complications of cocaine: alkaloidal versus hydrochloride--a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8628469" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Intracranial hemorrhage associated with cocaine abuse: a prospective autopsy study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27574836" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Risk of Cardiovascular Diseases and Stroke Events in Methamphetamine Users: A 10-Year Follow-Up Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10871003" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Moyamoya-like vasculopathy from cocaine dependency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11151419" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Cognitive and emotional consequences of perimesencephalic subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10864620" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Long term follow up after perimesencephalic subarachnoid haemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Effectiveness of MDCT angiography for the detection of intracranial aneurysms in patients with nontraumatic subarchnoid hemorrhage</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29768368" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Meta-analysis of computed tomography angiography versus magnetic resonance angiography for intracranial aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17537490" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Pitfalls in the preoperative evaluation of subarachnoid hemorrhage without digital subtraction angiography: report on 2 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16931020" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Spontaneous subarachnoid haemorrhage with negative initial angiography: a review of 143 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33902872" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Subarachnoid Hemorrhage of Unknown Cause: Distribution and Role of Imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9836761" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : MR imaging in pretruncal nonaneurysmal subarachnoid hemorrhage: is it worthwhile?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9493179" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : The need for repeat angiography in subarachnoid haemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9406201" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : False-negative angiograms in subarachnoid haemorrhage due to intracranial aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8773268" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : The negative angiogram in subarachnoid haemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14643914" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : "Occult" ruptured cerebral aneurysms revealed by repeat angiography: result from a large retrospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3670574" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Subarachnoid hemorrhage of unknown cause.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12816270" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Subarachnoid hemorrhage without evident cause on initial angiography studies: diagnostic yield of subsequent angiography and other neuroimaging tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10659015" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Use of spiral computerized tomography angiography in patients with subarachnoid hemorrhage in whom subtraction angiography did not reveal cerebral aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31677961" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : The Spectrum of Nontraumatic Convexity Subarachnoid Hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16757828" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Nonaneurysmal convexity subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21972883" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Clinical outcome of spontaneous non-aneurysmal subarachnoid hemorrhage in 108 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25680661" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Diffuse patterns of nonaneurysmal subarachnoid hemorrhage originating from the Basal cisterns have predictable vasospasm rates similar to aneurysmal subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27410409" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Non-aneurysmal spontaneous subarachnoid hemorrhage: perimesencephalic versus non-perimesencephalic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19277905" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Clinical differences between angiographically negative, diffuse subarachnoid hemorrhage and perimesencephalic subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29594703" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Risk factors for shunt dependency in patients suffering from spontaneous, non-aneurysmal subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26348436" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Health-Related Quality-of-Life Outcomes: Comparing Patients With Aneurysmal and Nonaneurysmal Subarachnoid Hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23332204" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Immediate coma and poor outcome in subarachnoid haemorrhage are independently associated with an aneurysmal origin.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
